您的购物车当前为空
USL311 是选择性 CXCR4拮抗剂,可防止基质细胞衍生因子 1(SDF-1 或 CXCL12)与 CXCR4 结合。它抑制 CXCR4 活化并减少表达 CXCR4 的肿瘤细胞的增殖和迁移,具有抗肿瘤活性。


为众多的药物研发团队赋能,
让新药发现更简单!
USL311 是选择性 CXCR4拮抗剂,可防止基质细胞衍生因子 1(SDF-1 或 CXCL12)与 CXCR4 结合。它抑制 CXCR4 活化并减少表达 CXCR4 的肿瘤细胞的增殖和迁移,具有抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 328 | In Stock | |
| 5 mg | ¥ 828 | In Stock | |
| 10 mg | ¥ 1,320 | In Stock | |
| 25 mg | ¥ 2,650 | In Stock | |
| 50 mg | ¥ 4,130 | In Stock | |
| 100 mg | ¥ 5,880 | In Stock | |
| 200 mg | ¥ 7,950 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 768 | In Stock |
USL311 相关产品
| 产品描述 | USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4. USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity. |
| 分子量 | 422.57 |
| 分子式 | C24H34N6O |
| CAS No. | 1373268-67-7 |
| Smiles | CC(C)N1CCC(CC1)N1CCCN(CC1)c1cccc(n1)C(=O)Nc1ccncc1 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMSO: < 1 mg/mL (insoluble or slightly soluble), Sonication is recommended. |
评论内容